Introduction
Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS), characterized by demyelination, focal inflammatory infiltrates and axonal damage [1, 2] . Several brain areas are affected, including but not limited to the cerebellum, brainstem, optic nerves and spinal cord [2] .
Studies revealed atrophy of the temporal and frontal cortical areas, as well as demyelination in the thalamus, basal ganglia, hypothalamus, hippocampus, cerebellum and neocortex [3] .
MS clinical symptoms include sensory or motor impairment, ataxia, spasticity, fatigue, and cognitive impairment [3] .
Experimental autoimmune encephalomyelitis (EAE) is the most commonly used experimental model for MS induction [4] . EAE can be induced in rodents by immunization with myelin constituents, such as myelin basic protein, myelin oligodendrocyte glycoprotein (MOG) and proteolipid protein [5] . A subcutaneous injection of the antigen in complete Freund's adjuvant (CFA) followed by two intraperitoneal injections of pertussis toxin (on the day of immunization and two days later) induces activation of myelin-specific T lymphocytes in the periphery and its migration into the CNS where T cells are reactivated by antigenpresenting cells leading to a subsequent inflammatory cascade and, eventually, demyelination and axonal degeneration [6] .
Following EAE induction, activated macrophages and microglial cells produce multiple mediators of tissue damage, including proteases, nitric oxide (NO) and reactive oxygen species (ROS), resulting in neurodegeneration [7] . ROS generated by macrophages appear to be involved in demyelination and axonal damage induced by EAE [8] . ROS derived from mononuclear cells mediate oxidation of total DNA as well as mitochondrial DNA in patients with MS [9, 10] . Moreover, evidence of lipid peroxidation has been described in exhaled breath samples of MS patients [11] .
Additional studies have shown decreased levels of antioxidant enzymes in blood and cerebrospinal fluid of MS patients [12, 13] . NADPH oxidases (Noxes) are a family of enzymes able to catalyze the production of ROS. The prototypical Nox, the Nox2 isoform, prevented myelin phagocytosis by peritoneal macrophages [8] . Furthermore, Nox2 mRNA expression was found to be upregulated in spinal cord in both relapsing-remitting and chronic models of EAE [16] . In MS patients, Nox2 was shown to be upregulated in activated microglia found in demyelinating and chronic MS lesions in brain tissue [17] . In a different study, it has been shown that microglial cells express Nox2 in preactive MS lesions, suggesting that microglial Nox2-derived ROS might be involved in the pathogenesis of MS [18] . A study using p47 phox knockout mice showed that Noxes inhibit the macrophage-derived NO, a strong inhibitor of T cell proliferation, which could be involved in the resistance of these animals to active EAE induction [19] . 
Material and Methods

Animals
Female ten week-old gp91 phox-/-mice (obtained from Jackson Laboratories, Maine, USA) (n = 50)
in the C57BL/6 background were used for this study. Controls for gp91 phox-/-mice were C57BL/6 mice (gp91 phox+/+ mice -obtained from Jackson Laboratories, Maine, USA, n = 50 
Western blotting
Mice were sacrificed and the regions of 
Real-time PCR
Tissue from the brain regions of interest was collected, homogenized in 1 ml TRIzol ΔCt method for quantification [22] . Primer sequences are indicated in Table 1 .
Cytokine ELISAs
IL-4, IL-6 and IL-10 levels in brain tissue were measured using specific ELISA kits according to the manufacturer's instructions (R&D Systems). 
Statistical analysis
Results
Effect of EAE on p47phox expression
In both structures analyzed p47 
Nox2 deletion abrogates GFAP protein expression induced by EAE
Western blotting was used to quantitatively evaluate GFAP protein expression in the striatum and motor cortex following EAE induction. In both striatum and motor cortex, an increase in GFAP protein expression was observed in Nox2 +/+ mice (p<0.05 and p<0.01, respectively), which was abrogated in Nox2 
Nox2 mediates proinflammatory cytokine induction following EAE
To determine whether Nox2 regulates cytokine induction, we first examined their mRNA and expression levels after EAE induction. Twenty days following EAE induction, IL1β, MCP-1 and IL-6 mRNA expression were found significantly increased in both striatum ( Figure 4A ; p<0.01; p<0.01and p<0.01vs control, respectively) and motor cortex ( Figure 4B; 
Effect of Nox2 deletion on the induction of anti inflammatory cytokines following EAE
In order to determine the effect of Nox2 
Discussion
In the present study, we present evidence to support our hypothesis that Nox2 plays an important role on the neuroinflammation induced by EAE. Our findings suggest that The human Nox2 gene is associated with MS and its expression is correlated with disease severity [23] . all found increased after MOG-induced EAE.
The Nuclear factor-erythroid 2-related factor 2 (Nrf2), a transcription factor that regulates genetic expression of many protective antioxidant enzymes, can be responsible for this neuroinflammatory response, since all these subunits were also significantly increased in Nrf2 knockout mice compared to the WT mice following EAE induction [27] .
Nox2 has been implicated in several neuropathological conditions [26, 28] . We have recently shown that Nox2 deletion protects mice against cognitive impairment induced by streptozotocin [28] . In the present study, Nox2 deletion significantly decreased clinical signs of EAE induced by the treatment with MOG35-55.
In agreement with our data, Nox2 knockdown improved clinical scores, prevented body weight loss and oxidative stress-induced nitrotyrosine formation in a mouse model of EAE [29] . It has been demonstrated that Nox2 alters the pattern of proteolytic digestion. Astrocytes play a critical role in MS progression. They have been shown to inhibit remyelination and axonal regeneration by releasing several cytotoxic factors and also by forming a glial scar [31] . MS patients exhibited increased expression of GFAP in MS lesions [32] and in the cerebrospinal fluid [33] . Similarly, up-regulation of GFAP has been described in the spinal cord of mice in the chronic phase of EAE induced by MOG [33] . In our study we observed that EAE induction increased GFAP expression in striatum and motor cortex. Nox2 It has been previously demonstrated that the expression of IL-6 is increased in macrophages and astrocytes in MS [35] . Moreover, its concentration was found elevated in serum and CSF [36] . IL-6 blockade by the treatment with an anti-IL-6 receptor monoclonal antibody inhibited the development of EAE in mice [37] .
Corroborating our data, elevated levels of IL-6
have been described in CSF [38] and in brain structures in experimental models of MS [39] . IL-1β has been shown to be released by monocytes, microglia, astrocytes and brain endothelial cells and it is involved in inflammatory reactions within the CNS. Similarly to IL-6, enhanced levels of IL-1β have been described to be increased in MS lesions [40] . Of note, the correlation between IL-6, IL-1β and Nox2 was demonstrated in a study involving traumatic brain injury (TBI). TBI significantly increased mRNA levels of IL-6 and IL-1β in in the cortex, which was attenuated upon Nox2 knockdown [41] . Nox2 deletion has also been shown to inhibit streptozotocin-induced IL1β production in the hippocampus [28] .
MCP-1, a monocyte chemoattractant, is produced by several immune and nonimmune cells [42] . In MS, this chemokine has been demonstrated to be released from astrocytes and macrophages and it seems to play a role in the demyelination of the CNS [43] . Increased expression of MCP-1 has been detected in astrocytes in the spinal cord following EAE induction [44] . Diphenyliodonium, a non- 
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